{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:37:13Z","timestamp":1762004233370},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,7,9]],"date-time":"2010-07-09T00:00:00Z","timestamp":1278633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s10552-010-9598-2","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T09:59:38Z","timestamp":1278583178000},"page":"1693-1700","source":"Crossref","is-referenced-by-count":24,"title":["A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program"],"prefix":"10.1007","volume":"21","author":[{"given":"Eduardo","family":"Lazcano-Ponce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila T.","family":"L\u00f6rincz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Salmer\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivonne","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Hern\u00e1ndez-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,9]]},"reference":[{"issue":"2","key":"9598_CR1","first-page":"162","volume":"97","author":"G Ogedegbe","year":"2005","unstructured":"Ogedegbe G, Cassells AN, Robinson CM, DuHamel K, Tobin JN, Sox CH, Dietrich AJ (2005) Perceptions of barriers and facilitators of cancer early detection among low-income minority women in community health centers. J Natl Med Assoc 97(2):162\u2013170","journal-title":"J Natl Med Assoc"},{"issue":"Suppl 3","key":"9598_CR2","doi-asserted-by":"crossref","first-page":"S449","DOI":"10.1590\/S0036-36342003000900020","volume":"45","author":"E Lazcano-Ponce","year":"2003","unstructured":"Lazcano-Ponce E, Alonso P, Ruiz-Moreno JA, Hern\u00e1ndez-Avila M (2003) Recommendations for cervical cancer screening programs in developing countries. The need for equity and technological development. Salud Publica Mex 45(Suppl 3):S449\u2013S462","journal-title":"Salud Publica Mex"},{"issue":"3","key":"9598_CR3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/jwh.1999.8.399","volume":"8","author":"EC Lazcano-Ponce","year":"1999","unstructured":"Lazcano-Ponce EC, Castro R, Allen B, N\u00e1jera P, Alonso de Ru\u00edz PA, Hern\u00e1ndez-Avila M (1999) Barriers to early detection of cervical-uterine cancer in Mexico. J Womens Health 8(3):399\u2013408","journal-title":"J Womens Health"},{"key":"9598_CR4","unstructured":"Chu KC, Miller BA, Springfield SA (2007) Measures of racial\/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J Natl Med Assoc 99(10):1092\u20131100 (1102\u20131104)"},{"issue":"1","key":"9598_CR5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5858\/2008-132-16-TEOCMO","volume":"132","author":"SS Raab","year":"2008","unstructured":"Raab SS, Jones BA, Souers R, Tworek JA (2008) The effect of continuous monitoring of cytologic-histologic correlation data on cervical cancer screening performance. Arch Pathol Lab Med 132(1):16\u201322","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"9598_CR6","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.5858\/2007-131-1525-TVOMHP","volume":"131","author":"JA Tworek","year":"2007","unstructured":"Tworek JA, Jones BA, Raab S, Clary KM, Walsh MK (2007) The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions. Arch Pathol Lab Med 131(10):1525\u20131531","journal-title":"Arch Pathol Lab Med"},{"key":"9598_CR7","doi-asserted-by":"crossref","unstructured":"DeMay RM (1996) Cytopathology of false negatives preceding cervical carcinoma. Am J Obstet Gynecol 175(4 Pt 2):1110\u20131113","DOI":"10.1016\/S0002-9378(96)70013-3"},{"issue":"6","key":"9598_CR8","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/01.AOG.0000143881.53058.81","volume":"104","author":"K Behbakht","year":"2004","unstructured":"Behbakht K, Lynch A, Teal S, Degeest K, Massad S (2004) Social and cultural barriers to Papanicolaou test screening in an urban population. Obstet Gynecol 104(6):1355\u20131361","journal-title":"Obstet Gynecol"},{"key":"9598_CR9","doi-asserted-by":"crossref","unstructured":"Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Syrj\u00e4nen S, Favalli C, Syrj\u00e4nen K, on behalf of the HPV-Pathogen ISS Study Group (2008) Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling. Int J Gynecol Pathol","DOI":"10.1097\/PGP.0b013e318159cbc0"},{"key":"9598_CR10","doi-asserted-by":"crossref","unstructured":"Baseman JG, Kulasingam SL, Harris TG, Hughes JP, Kiviat NB, Mao C, Koutsky LA (2008) Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States. Am J Obstet Gynecol","DOI":"10.1016\/j.ajog.2007.11.051"},{"key":"9598_CR11","doi-asserted-by":"crossref","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N, New Technologies for Cervical Cancer Screening Working Group (2008) Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 100(7):492\u2013501","DOI":"10.1093\/jnci\/djn065"},{"key":"9598_CR12","doi-asserted-by":"crossref","unstructured":"Naucler P, Ryd W, T\u00f6rnberg S, Strand A, Wadell G, Elfgren K, R\u00e5dberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J (2009) Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst 101(2):88\u201399","DOI":"10.1093\/jnci\/djn444"},{"key":"9598_CR13","doi-asserted-by":"crossref","unstructured":"Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutl\u00e9e F, Franco EL, Canadian Cervical Cancer Screening Trial Study Group (2007) Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357(16):1579\u20131588","DOI":"10.1056\/NEJMoa071430"},{"key":"9598_CR14","doi-asserted-by":"crossref","unstructured":"Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van Groningen K, Boon ME, Ruitinga W, van Ballegooijen M, Snijders PJ, Meijer CJ (2007) Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370(9601):1764\u20131772","DOI":"10.1016\/S0140-6736(07)61450-0"},{"key":"9598_CR15","doi-asserted-by":"crossref","unstructured":"Kotaniemi-Talonen L, Nieminen P, Anttila A, Hakama M (2005) Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br J Cancer 93(8):862\u2013867","DOI":"10.1038\/sj.bjc.6602799"},{"key":"9598_CR16","doi-asserted-by":"crossref","unstructured":"Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, Gilham C, Baysson H, Roberts C, Dowie R, Desai M, Mather J, Bailey A, Turner A, Moss S, Peto J (2009) HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 10(7):672\u2013682","DOI":"10.1016\/S1470-2045(09)70156-1"},{"key":"9598_CR17","doi-asserted-by":"crossref","unstructured":"Cuzick J, Szarewski A, Mesher D, Cadman L, Austin J, Perryman K, Ho L, Terry G, Sasieni P, Dina R, Soutter WP (2008) Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-results from the Hammersmith study. Int J Cancer","DOI":"10.1002\/ijc.23339"},{"key":"9598_CR18","doi-asserted-by":"crossref","unstructured":"Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA (2002) Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 288(14):1749\u20131757","DOI":"10.1001\/jama.288.14.1749"},{"key":"9598_CR19","doi-asserted-by":"crossref","unstructured":"Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A (2009) Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 101(23):1612\u20131623","DOI":"10.1093\/jnci\/djp367"},{"key":"9598_CR20","unstructured":"Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference (2007) 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197(4):346\u2013355"},{"key":"9598_CR21","doi-asserted-by":"crossref","unstructured":"Bistoletti P, Sennf\u00e4lt K, Dillner J (2008) Cost-effectiveness of primary cytology and HPV DNA cervical screening. Int J Cancer 122(2):372\u2013376","DOI":"10.1002\/ijc.23124"},{"issue":"5","key":"9598_CR22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jnci\/djn019","volume":"100","author":"JD Goldhaber-Fiebert","year":"2008","unstructured":"Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ (2008) Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination. J Natl Cancer Inst 100(5):308\u2013320","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"9598_CR23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ncponc0770","volume":"4","author":"CM Wheeler","year":"2007","unstructured":"Wheeler CM (2007) Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nat Clin Pract Oncol 4(4):224\u2013235","journal-title":"Nat Clin Pract Oncol"},{"key":"9598_CR24","unstructured":"Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ (2008) Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30\u00a0years and older. Int J Cancer 124(3):516\u2013520"},{"key":"9598_CR25","doi-asserted-by":"crossref","unstructured":"Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T, Joint European Cohort Study (2008) Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 337:a1754","DOI":"10.1136\/bmj.a1754"},{"key":"9598_CR26","doi-asserted-by":"crossref","unstructured":"Jhala D, Eltoum I (2007) Barriers to adoption of recent technology in cervical screening. Cytojournal 4:16","DOI":"10.1186\/1742-6413-4-16"},{"key":"9598_CR27","unstructured":"(2008) Is HPV testing better than a pap test? Not just yet. Mayo Clin Womens Healthsource 12(4):3"},{"issue":"5","key":"9598_CR28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/dc.20018","volume":"30","author":"LP Howell","year":"2004","unstructured":"Howell LP, Zhou H, Wu W, Davis R (2004) Significance of subclassifying high-grade squamous intraepithelial lesions into moderate dysplasia\/CIN II versus severe dysplasia\/CIN III\/CIS in the Bethesda System terminology. Diagn Cytopathol 30(5):362\u2013366","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"9598_CR29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1447-0756.1996.tb01081.x","volume":"22","author":"AT L\u00f6rincz","year":"1996","unstructured":"L\u00f6rincz AT (1996) Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 22(6):629\u2013636","journal-title":"J Obstet Gynaecol Res"},{"key":"9598_CR30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0010-4825(98)00047-X","volume":"29","author":"T Fagan","year":"1999","unstructured":"Fagan T (1999) Exact 95% confidence intervals for differences in binomial proportions. Comput Biol Med 29:83\u201387","journal-title":"Comput Biol Med"},{"key":"9598_CR31","doi-asserted-by":"crossref","unstructured":"Ronco G, Cuzick J, Segnan N, Brezzi S, Carozzi F, Folicaldi S, Dalla Palma P, Del Mistro A, Gillio-Tos A, Giubilato P, Naldoni C, Polla E, Iossa A, Zorzi M, Confortini M, Giorgi-Rossi P, NTCC working group (2007) HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer 43(3):476\u2013480","DOI":"10.1016\/j.ejca.2006.11.013"},{"key":"9598_CR32","doi-asserted-by":"crossref","unstructured":"Sheriff SK, Petry KU, Ikenberg H, Crouse G, Mazonson PD, Santas CC (2007) An economic analysis of human papillomavirus triage for the management of women with atypical and abnormal Pap smear results in Germany. Eur J Health Econ","DOI":"10.1007\/s10198-007-0038-5"},{"issue":"1","key":"9598_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dc.20576","volume":"35","author":"M Reid-Nicholson","year":"2007","unstructured":"Reid-Nicholson M, Gatscha RM, Riedel ER, Lin O (2007) Atypical squamous cells, cannot exclude high grade intraepithelial lesion (ASC-H): does HPV matter? Diagn Cytopathol 35(1):1\u20135","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"9598_CR34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5858\/2008-132-16-TEOCMO","volume":"132","author":"SS Raab","year":"2008","unstructured":"Raab SS, Jones BA, Souers R, Tworek JA (2008) The effect of continuous monitoring of cytologic-histologic correlation data on cervical cancer screening performance. Arch Pathol Lab Med 132(1):16\u201322","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"9598_CR35","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1158\/1055-9965.EPI-07-2659","volume":"17","author":"E Lazcano-Ponce","year":"2008","unstructured":"Lazcano-Ponce E, Palacio-Mejia LS, Allen-Leigh B, Yunes-Diaz E, Alonso P, Schiavon R, Hernandez-Avila M (2008) Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology. Cancer Epidemiol Biomarkers Prev 17(10):2808\u20132817","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9598_CR36","doi-asserted-by":"crossref","unstructured":"Eltoum IA, Roberson J (2007) Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS). Cancer 111(1):34\u201340","DOI":"10.1002\/cncr.22487"},{"key":"9598_CR37","doi-asserted-by":"crossref","unstructured":"Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mah\u00e9 C, Wright TC, Alliance for Cervical Cancer Prevention Cost Working Group (2005) Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 353(20):2158\u20132168","DOI":"10.1056\/NEJMsa044278"},{"key":"9598_CR38","doi-asserted-by":"crossref","unstructured":"Goldie SJ, Kim JJ, Myers E (2006) Chapter 19: cost-effectiveness of cervical cancer screening. Vaccine 24(Suppl 3):S164\u2013S170","DOI":"10.1016\/j.vaccine.2006.05.114"},{"issue":"1","key":"9598_CR39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.6004\/jnccn.2008.0009","volume":"6","author":"KJ Kimball","year":"2008","unstructured":"Kimball KJ, Huh WK (2008) Cytology versus high-risk HPV testing for follow-up of HPV-positive women without CIN. J Natl Compr Canc Netw 6(1):96\u2013100","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"9598_CR40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00128360-200204000-00006","volume":"6","author":"S Syrj\u00e4nen","year":"2002","unstructured":"Syrj\u00e4nen S, Shabalova IP, Petrovichev N, Kozachenko VP, Zakharova T, Pajanidi J, Podistov JI, Chemeris G, Sozaeva LG, Lipova EV, Tsidaeva I, Ivanchenko OG, Pshepurko AA, Zakharenko S, Nerovjna R, Kljukina LB, Erokhina OA, Branovskaja MF, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Tosi P, Cintorino M, Santopietro R, Syrj\u00e4nen KJ (2002) Human papillomavirus testing and conventional Pap smear cytology as optional screening tools of women at different risks for cervical cancer in the countries of the former Soviet Union. J Low Genit Tract Dis 6(2):97\u2013110","journal-title":"J Low Genit Tract Dis"},{"key":"9598_CR41","doi-asserted-by":"crossref","unstructured":"Longatto-Filho A, Erzen M, Branca M, Roteli-Martins C, Naud P, Derchain SF, Hammes L, Sarian LO, Bragan\u00e7a JF, Matos J, Gontijo R, Lima T, Maeda MY, Tatti S, Syrj\u00e4nen S, Dores G, L\u00f6rincz A, Syrj\u00e4nen K (2006) Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study. Int J Gynecol Cancer 16(3):955\u2013962","DOI":"10.1111\/j.1525-1438.2006.00582.x"},{"key":"9598_CR42","doi-asserted-by":"crossref","unstructured":"Franco EL, Cuzick J, Hildesheim A, de Sanjos\u00e9 S (2006) Chapter 20: issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine 24(Suppl 3):S171\u2013S177","DOI":"10.1016\/j.vaccine.2006.05.061"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-010-9598-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-010-9598-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-010-9598-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T02:36:23Z","timestamp":1635647783000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-010-9598-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,9]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["9598"],"URL":"https:\/\/doi.org\/10.1007\/s10552-010-9598-2","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,9]]}}}